Denosumab for Elderly Men with Osteoporosis: A Cost-Effectiveness Analysis from the US Payer Perspective

Purpose. To evaluate the cost-effectiveness of denosumab versus other osteoporotic treatments in older men with osteoporosis from a US payer perspective. Methods. A lifetime cohort Markov model previously developed for postmenopausal osteoporosis (PMO) was used. Men in the model were 78 years old, w...

Descripción completa

Detalles Bibliográficos
Autores principales: Silverman, Stuart, Agodoa, Irene, Kruse, Morgan, Parthan, Anju, Orwoll, Eric
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4689973/
https://www.ncbi.nlm.nih.gov/pubmed/26783494
http://dx.doi.org/10.1155/2015/627631

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4689973/
https://www.ncbi.nlm.nih.gov/pubmed/26783494
http://dx.doi.org/10.1155/2015/627631

Ejemplares similares